Protein targeting
Protein targeting, also known as protein sorting, is the essential cellular process by which newly synthesized proteins are directed from their site of synthesis on ribosomes to specific locations within the cell or for export outside it, ensuring proper function and compartmentalization within cells across all organisms.[1] This process relies on inherent sorting signals embedded in the protein's amino acid sequence, which are recognized by dedicated receptor proteins and transport machinery to guide proteins to destinations such as the endoplasmic reticulum (ER), mitochondria, nucleus, peroxisomes, lysosomes, or the plasma membrane.[1] Defects in protein targeting can lead to severe disorders, such as I-cell disease, a lysosomal storage disorder caused by mislocalization of enzymes due to mutations in targeting signals.[2] In eukaryotic cells, protein targeting occurs primarily through two mechanisms: co-translational and post-translational translocation. Co-translational targeting involves proteins being translocated across or into membranes during their synthesis on ribosomes, most notably for secretory proteins and those destined for the ER, Golgi apparatus, lysosomes, or plasma membrane via the vesicular transport pathway.[1] This process is mediated by the signal recognition particle (SRP), which binds to an N-terminal signal sequence—a short stretch of 15–30 hydrophobic amino acids—on the emerging polypeptide, pausing translation until the ribosome docks at the ER membrane's translocon.[1] Post-translational targeting, in contrast, occurs after protein synthesis is complete in the cytosol and is used for import into organelles like mitochondria, chloroplasts (in plants), peroxisomes, and the nucleus, where proteins fold and are then actively transported through specific pores or channels.[1] The specificity of targeting is determined by diverse signal sequences or signal patches, which vary by destination organelle and are often cleaved after import to allow proper folding. For instance, mitochondrial proteins feature an amphipathic N-terminal presequence with positively charged residues that directs them to translocases in the outer and inner membranes, while nuclear proteins contain nuclear localization signals (NLS)—short basic amino acid motifs like lysine or arginine clusters—that interact with importins for passage through nuclear pore complexes.[1] Peroxisomal targeting signals (PTS) are typically C-terminal tripeptides, such as serine-lysine-leucine (SKL), recognized by cytosolic receptors like PEX5 for import.[1] Vesicular transport in the endomembrane system further refines sorting, with proteins acquiring additional signals in the Golgi for delivery to lysosomes (e.g., mannose-6-phosphate tags) or secretion.[1] Overall, these mechanisms maintain cellular homeostasis by preventing mislocalization, which could otherwise disrupt organelle function or trigger quality control degradation pathways.[2]Fundamentals
Definition and Cellular Importance
Protein targeting is the biological process by which newly synthesized proteins are directed from their sites of synthesis, typically ribosomes in the cytosol, to specific intracellular destinations such as organelles, membranes, or the extracellular space, utilizing dedicated signals and molecular machinery to ensure precise localization.[3] This directed transport involves recognition of targeting sequences by chaperones and receptors, followed by translocation across or into membranes via specialized complexes.[4] The cellular importance of protein targeting lies in its role in maintaining compartmentalization, which is essential for proper protein folding, functional assembly, and execution of specialized processes; for instance, it enables ATP production in mitochondria, lipid and protein synthesis in the endoplasmic reticulum (ER), and secretion of extracellular matrix components.[5] Without accurate targeting, proteins may aggregate in the cytosol, undergo premature degradation, or engage in off-target interactions, leading to cellular dysfunction; studies indicate that mistargeting can affect 5–30% of translocated proteins in experimental models, underscoring the need for quality control mechanisms.[6] In eukaryotes, roughly one-third of the proteome requires targeting to the ER for processing and export, while approximately 13% is directed to mitochondria, illustrating the process's broad impact on cellular proteome organization.[5][7] These targeting mechanisms exhibit remarkable evolutionary conservation, originating in prokaryotes as basic translocation systems for membrane insertion and cargo transport, which were later adapted in eukaryotes to support endosymbiotic organelles like mitochondria and chloroplasts.[3] This conservation reflects the fundamental role of spatial protein organization in life across domains, with eukaryotic innovations building upon prokaryotic precursors such as the Sec and Tat pathways.[3]Historical Milestones
In the 1950s and 1960s, George Palade's pioneering use of electron microscopy revealed the secretory pathway in eukaryotic cells, identifying the rough endoplasmic reticulum as the primary site for synthesizing secretory and membrane proteins, with their subsequent transport through the Golgi apparatus to secretory vesicles.[8] This work established the foundational framework for understanding intracellular protein trafficking and earned Palade the Nobel Prize in Physiology or Medicine in 1974, shared with Albert Claude and Christian de Duve. A major breakthrough came in 1971 when Günter Blobel and David Sabatini proposed the signal hypothesis, suggesting that proteins destined for the secretory pathway or ER membrane contain an N-terminal signal peptide that directs their targeting during or after synthesis. Experimental validation followed, including the 1975 discovery by Blobel and Bernhard Dobberstein of the signal recognition particle (SRP), a ribonucleoprotein complex that binds the signal peptide on nascent polypeptides to facilitate co-translational targeting to the ER. Blobel's contributions culminated in his receipt of the Nobel Prize in Physiology or Medicine in 1999.[9] Parallel developments in the 1970s and 1980s focused on organelle-specific targeting. Gottfried Schatz demonstrated that most mitochondrial proteins are encoded by nuclear genes, synthesized in the cytosol, and imported post-translationally via N-terminal presequences, with his 1979 experiments confirming this for cytochrome c1. Schatz's group further identified components of the import machinery, including the TOM complex in the outer mitochondrial membrane through isolation of the 42 kDa ISP42 protein in 1989.[10] For chloroplasts, Colin Robinson and colleagues in the 1980s characterized transit peptides as N-terminal targeting signals and purified processing proteases that cleave them upon import, as detailed in their 1984 study on pea chloroplast proteases.[11] Post-2000 advances leveraged structural biology to visualize targeting mechanisms at atomic resolution. Cryo-electron microscopy (cryo-EM) structures of the Sec61 translocon, such as the 2014 mammalian ribosome-Sec61 complex at 3.4 Å resolution by Rebecca M. Voorhees et al., illuminated the channel's role in co- and post-translational translocation across the ER membrane.[12] Concurrently, studies reinforced the essential function of Hsp70 chaperones in post-translational targeting, with 2006 experiments by M. Mokranjac et al. showing that individual Hsp70 molecules accelerate polypeptide unfolding and import into mitochondria without additional factors.[13] More recent work includes the 2023 cryo-EM structure of the ribosome-Sec61 complex bound to the translocon-associated protein (TRAP) complex by Pavel Itskanov et al., providing further insights into accessory protein interactions during translocation.[14]| Year | Scientist(s) | Breakthrough |
|---|---|---|
| 1950s–1960s | George Palade | Elucidation of the secretory pathway via electron microscopy, identifying rough ER's role in protein synthesis and trafficking.[8] |
| 1971 | Günter Blobel, David Sabatini | Proposal of the signal hypothesis for ER targeting via N-terminal signal peptides. |
| 1975 | Günter Blobel, Bernhard Dobberstein | Discovery of the signal recognition particle (SRP) for co-translational targeting. |
| 1979 | Gottfried Schatz | Demonstration of post-translational import of mitochondrial proteins like cytochrome c1. |
| 1984 | Colin Robinson et al. | Identification and purification of chloroplast transit peptide processing proteases.[11] |
| 1989 | Gottfried Schatz et al. | Isolation of ISP42 as a key component of the mitochondrial outer membrane import complex (TOM).[10] |
| 2014 | Rebecca M. Voorhees et al. | Cryo-EM structure of the mammalian ribosome-Sec61 translocon complex at 3.4 Å resolution.[12] |
| 2023 | Pavel Itskanov et al. | Cryo-EM structure of the ribosome-Sec61 complex with the TRAP complex.[14] |